---
layout: post
title: "Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment; Withdrawal"
date: 2026-02-05 18:57:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01928
original_published: 2022-02-04 00:00:00 +0000
significance: 8.00
---

# Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment; Withdrawal

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** February 04, 2022 00:00 UTC
**Document Number:** 2022-01928

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the withdrawal of the proposed rule "Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment," published in the Federal Register on July 14, 2011. FDA is taking this action because the proposed changes are duplicative of another FDA proposed rulemaking, which is also being published in this issue of the Federal Register, that is intended to conform with newly established definitions and requirements set out by the Drug Supply Chain Security Act of 2013 (DSCSA).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/02/04/2022-01928/removal-of-certain-requirements-related-to-the-prescription-drug-marketing-act-opportunity-for)
- API: https://www.federalregister.gov/api/v1/documents/2022-01928

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
